DC-S239
DC-S239 is a potent and selective small molecule inhibitor of the histone methyltransferase SETD7, exhibiting an IC50 of 4.59 μM. It is a valuable research tool for studying epigenetic regulation in oncology, with applications in both in vitro biochemical assays and cellular studies exploring its anticancer mechanisms.
Product Specifications
CAS Number
303141-21-1
Product Name Alternative
Anti-cancer, DC-S 239, DC-S-239, Ethyl 2amino4methyl5[ (3nitrophenyl) carbamoyl]thiophene3carboxylate, Ethyl 2 amino 4 methyl 5 [ (3 nitrophenyl) carbamoyl]thiophene 3 carboxylate, Inhibitor, MCF7, Histone Methyltransferase, HistoneMethyltransferase, HL60, MV4-11, inhibit, SETD7, SET7 inhibitor
Field of Research
Epigenetics & Chromatin
Purity
99.36% (May vary between batches)
Solubility
DMSO:5.5 mg/mL (15.74 mM)
Smiles
CCOC (=O) c1c (N) sc (C (=O) Nc2cccc (c2) [N+] ([O-]) =O) c1C
Molecular Formula
C15H15N3O5S
Molecular Weight
349.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6122986-01 0.1 mL
Cyclin B1 (CCNB, CCNB1, CCNB1_HUMAN, G2 Mitotic Specific Cyclin B1) (AP)
Sign In for Pricing
View Details MBS6122986-02 5x 0.1 mL
Cyclin B1 (CCNB, CCNB1, CCNB1_HUMAN, G2 Mitotic Specific Cyclin B1) (AP)
Sign In for Pricing
View Details 
031674-ML550 100 µL
AF9, CT (K486) (MLLT3, AF9, YEATS3, Protein AF-9, ALL1-fused gene from chromosome 9 protein, Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein, YEATS domain-containing protein 3) (MaxLight 550) discontinued
Sign In for Pricing
View Details 